While pregnant and non-pregnant women have shown similar antibody responses to SARS-CoV-2 vaccination [2], several studies have illustrated reduced vaccine responses in patients with IBD taking anti-tumor necrosis factor (TNF) agents or Jak kinase (JAK) inhibitors [3,4]. Here, TNF is linked to inflammatory bowel disease.